N

NextCure Inc
NASDAQ:NXTC

Watchlist Manager
NextCure Inc
NASDAQ:NXTC
Watchlist
Price: 1.67 USD 1.21% Market Closed
Updated: May 19, 2024

NextCure Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NextCure Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
N
NextCure Inc
NASDAQ:NXTC
Selling, General & Administrative
-$18.6m
CAGR 3-Years
-1%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is NextCure Inc's Selling, General & Administrative?
Selling, General & Administrative
-18.6m USD

Based on the financial report for Mar 31, 2024, NextCure Inc's Selling, General & Administrative amounts to -18.6m USD.

What is NextCure Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-34%

Over the last year, the Selling, General & Administrative growth was 13%. The average annual Selling, General & Administrative growth rates for NextCure Inc have been -1% over the past three years , -34% over the past five years .